A detailed history of Planning Center, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Planning Center, Inc. holds 560 shares of LLY stock, worth $429,945. This represents 0.08% of its overall portfolio holdings.

Number of Shares
560
Previous 560 -0.0%
Holding current value
$429,945
Previous $507,000 2.17%
% of portfolio
0.08%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 22, 2024

SELL
$525.19 - $619.13 $1,050 - $1,238
-2 Reduced 0.36%
560 $326,000
Q2 2023

Jul 20, 2023

SELL
$350.74 - $468.98 $63,483 - $84,885
-181 Reduced 24.36%
562 $263,000
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $238,911 - $278,379
743 New
743 $271,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Planning Center, Inc. Portfolio

Follow Planning Center, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Center, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Planning Center, Inc. with notifications on news.